Geode Capital Management
SGTX

Geode Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Geode Capital Management’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$89.8K Sell
2022
Q4 		$42K Buy
2022
Q3 		$61K Buy
2022
Q2 		$100K Sell
2022
Q1 		$363K Buy
2021
Q4 		$646K Buy
2021
Q3 		$1.31M Buy
2021
Q2 		$1.44M Buy
2021
Q1 		$2.73M Buy
2020
Q4 		$813K Buy